FDA Adverse Event Injury Summary report: N

MICOR LENS FRAGMENTATION SYSTEM

MDR report key: 12035040 · Received June 21, 2021

Report

Report Number
3012123033-2021-00007
Event Type
Injury
Date Received
June 21, 2021
Date of Event
May 25, 2021
Report Date
June 21, 2021
Manufacturer
CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
Product Code
HQC
UDI-DI
00860000122368
PMA / PMN Number
K200584
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE MICOR EXTRACTOR WAS DISCARDED BY THE USER FACILITY AND IS NOT AVAILABLE FOR EVALUATION. THE DEVICE HISTORY RECORDS WERE REVIEWED FOR THIS MANUFACTURING LOT AND THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS THAT RELATE TO THE REPORTED EVENT. BASED ON THE INFORMATION REVIEWED, THERE IS NO EVIDENCE TO INDICATE THE PRESENCE OF A POTENTIAL QUALITY ISSUE WITH RESPECT TO MANUFACTURING, DESIGN, OR LABELING. THE DEVICE LABELING IDENTIFIES CAPSULAR RUPTURE AS A SAFETY RISK. MANUFACTURER'S REFERENCE #: (B)(4).

Description of Event or Problem · 1

A (B)(6) PATIENT UNDERWENT CATARACT SURGERY IN THE RIGHT EYE ON (B)(6) 2021 WHERE THE MICOR LENS FRAGMENTATION SYSTEM (EXTRACTOR AND DRIVE) WAS USED TO FRAGMENT AND REMOVE THE CATARACTOUS LENS. THE PATIENT'S POSTERIOR CAPSULE TORE DURING SURGERY. THE TEAR, DESCRIBED AS SMALL, WAS DETECTED WHILE USING THE MICOR DEVICE AND DURING CAPSULAR BAG POLISHING (AFTER THE SURGEON HAD IMPLANTED THE INTRAOCULAR LENS). ACCORDING TO THE COMPANY REPRESENTATIVE, IT APPEARED AS THOUGH THE SURGEON INADVERTENTLY CAPTURED A PORTION OF THE CAPSULE DURING IRRIGATION/ASPIRATION, WHICH RESULTED IN A POSTERIOR CAPSULAR BAG TEAR. THERE WAS NO VITREOUS PRESENT IN THE ANTERIOR CHAMBER AND THE SURGEON REPORTS NO ADVERSE IMPACT ON VISION OR SEQUELAE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
928587 MICOR LENS FRAGMENTATION SYSTEM PHACOFRAGMENTATION UNIT HQC CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC. FG-50621 FG21031001 00860000122368

Patients

Seq Age Sex Outcome Treatment
1 65 YR Required Intervention